Javascript must be enabled to continue!
Statewide Cancer Genomics Integration in Michigan
View through CrossRef
The Michigan Cancer Genetics Alliance (MCGA) was created in 2003, and facilitated by the MDCH Genomics Program. In parallel, the State Genetics Plan and the Michigan Cancer Strategic Plan identified the need to create MCGA to serve as an organization of cancer genetics professionals with the purposes to promote communication, serve as a source of expert information, and participate in the Michigan Cancer Consortium (MCC). MCGA and cancer genetics received further support by a Centers for Disease Control and Prevention Cooperative Agreement to develop state capacity for integration of genomics into chronic disease prevention programs (♯U58/CCU522826).Highlights of MCGA’s accomplishments include a six‐session course entitled, ‘Cancer Genomics for Public Health’, which was created and piloted for the MDCH Cancer Section. Additionally, MCGA has been working to enhance the state’s cancer surveillance system by addition of cancer genetics elements to the state cancer registry. MCGA members have representation on MCC subcommittees that are working to create risk assessment guidelines for breast, colorectal, and prostate cancer. MCGA is also addressing access to care, health disparities and health literacy issues.Michigan’s experience is one model of integrating cancer genomics knowledge into practice through partnerships and the development of projects and collaborations.
Title: Statewide Cancer Genomics Integration in Michigan
Description:
The Michigan Cancer Genetics Alliance (MCGA) was created in 2003, and facilitated by the MDCH Genomics Program.
In parallel, the State Genetics Plan and the Michigan Cancer Strategic Plan identified the need to create MCGA to serve as an organization of cancer genetics professionals with the purposes to promote communication, serve as a source of expert information, and participate in the Michigan Cancer Consortium (MCC).
MCGA and cancer genetics received further support by a Centers for Disease Control and Prevention Cooperative Agreement to develop state capacity for integration of genomics into chronic disease prevention programs (♯U58/CCU522826).
Highlights of MCGA’s accomplishments include a six‐session course entitled, ‘Cancer Genomics for Public Health’, which was created and piloted for the MDCH Cancer Section.
Additionally, MCGA has been working to enhance the state’s cancer surveillance system by addition of cancer genetics elements to the state cancer registry.
MCGA members have representation on MCC subcommittees that are working to create risk assessment guidelines for breast, colorectal, and prostate cancer.
MCGA is also addressing access to care, health disparities and health literacy issues.
Michigan’s experience is one model of integrating cancer genomics knowledge into practice through partnerships and the development of projects and collaborations.
Related Results
Abstract 5042: Using a statewide collaborative approach to improve tobacco cessation referral rates for cancer patients
Abstract 5042: Using a statewide collaborative approach to improve tobacco cessation referral rates for cancer patients
Abstract
Purpose:
Though tobacco use by cancer patients is associated with poor therapeutic outcomes, most oncologists do not regularly provide tobacc...
Abstract 1831: Cancer genomic resources and needs in the Latin American region
Abstract 1831: Cancer genomic resources and needs in the Latin American region
Abstract
In 2012, approximately 1,005,255 new cancer cases and 550,164 deaths from cancer occurred in both sexes in central and South American region, by 2025 and in...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
P2-13-09: First Statewide Experience with Telephone Delivery of Cancer Genetic Counseling.
P2-13-09: First Statewide Experience with Telephone Delivery of Cancer Genetic Counseling.
Abstract
Background: National guidelines and multiple professional medical societies recommend genetic counseling as the standard of care for women with a personal a...
Genomics and society: four scenarios for 2015
Genomics and society: four scenarios for 2015
This paper develops four alternative scenarios depicting possible futures for genomics applications within a broader social context. The scenarios integrate forecasts for future ge...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

